inscripta ^Companies

Inscripta is a digital genome engineering company that aims to transform how we address complex global challenges through their revolutionary tools. Their Lean Bioengineering approach combines Directed Evolution, CRISPR, and Machine Learning to make biomanufacturing scalable, cost-effective, and safe. The organization focuses on testing large sets of genetic solutions for improved traits, discovering beneficial genetic changes, and conducting combinatorial testing of these changes. They are able to integrate and test 1-10 genomic edits at a time, discovering 1-2 beneficial edits at a time. Inscripta's approach is 4x faster than state-of-the-art methods, 1,000x more cost-effective at $0.10/variant, and requires only 0.5-3 FTE/project, making them a leader in the field of digital genome engineering.